OTC Markets OTCPK - Delayed Quote USD

Cannabis Bioscience International Holdings, Inc. (CBIH)

Compare
0.0007 +0.0001 (+16.67%)
At close: November 22 at 2:27 PM EST
Loading Chart for CBIH
DELL
  • Previous Close 0.0006
  • Open 0.0007
  • Bid 0.0006 x --
  • Ask 0.0007 x --
  • Day's Range 0.0007 - 0.0007
  • 52 Week Range 0.0004 - 0.0020
  • Volume 4,004,072
  • Avg. Volume 2,247,996
  • Market Cap (intraday) 7.39M
  • Beta (5Y Monthly) -0.08
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date Sep 13, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Cannabis Bioscience International Holdings, Inc. provides educational systems that focuses on medical cannabis in the United States and Latin America, and internationally. The company offers services in the therapeutic areas of clinical trials; and relating to sleep disorders; including resulting infertility, through its fertility and sleep center in Houston, Texas. It also offers education, consulting, digital publishing, marketing, and franchising related to medical cannabis through its Pharmacology University. Cannabis Bioscience International Holdings, Inc. was founded in 2003 and is headquartered in Houston, Texas.

www.chnc-hdh.com

2

Full Time Employees

May 31

Fiscal Year Ends

Recent News: CBIH

View More

Performance Overview: CBIH

Trailing total returns as of 11/22/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CBIH
12.50%
S&P 500
25.15%

1-Year Return

CBIH
0.00%
S&P 500
31.54%

3-Year Return

CBIH
55.56%
S&P 500
32.67%

5-Year Return

CBIH
55.56%
S&P 500
32.67%

Compare To: CBIH

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CBIH

View More

Valuation Measures

Annual
As of 11/22/2024
  • Market Cap

    6.33M

  • Enterprise Value

    6.73M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    17.85

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    18.95

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -153.80%

  • Return on Assets (ttm)

    -643.81%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    354.91k

  • Net Income Avi to Common (ttm)

    -545.86k

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    969

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -351.14k

Research Analysis: CBIH

View More

Company Insights: CBIH

Research Reports: CBIH

View More

People Also Watch